Pricing

Log inSign up

ALX Oncology

0 followers

‌

ALX Oncology is a publicly traded, clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.

Industries

Biotechnology

Headquarters

Burlingame, United States

Employees

11-50

Links

Org chart

Jaume Pons
President & Chief Scientific Officer

Jaume Pons

Collapse
Sophia Randolph
Chief Medical Officer
Athanasios Tsiatis
SVP, Clinical Development
Yeong-Liang Lin
SVP, Drug Safety & Pharmacovigilance
Hank Stern
VP, Chemistry, Manufacturing & Controls
Susan Vermeir
VP, Regulatory Affairs & Quality
Hadi Falahatpisheh
VP, Preclinical Development
Marija Vrljic
VP, Antibody Technologies
Sue Naim
VP, Clinical Operations
Jeanne Jew
Chief Business Officer

Teams

+7

Clinical Development and Operations

10 members

+5

Leadership Team

8 members

+3

Regulatory Affairs and Compliance

6 members

Offices

Similar companies

Gameto

4 followers

Synthekine

3 followers

Tango Therapeutics

2 followers

Vera Therapeutics

2 followers

Kyverna Therapeutics

7 followers

Apogee Therapeutics

1 follower

Cargo

1 follower

Aura Biosciences

1 follower

Edgewise Therapeutics

1 follower

Cartesian Therapeutics

1 follower

Aviceda Therapeutics

1 follower

Explore companies